Page 107

UNOFFICIAL 1737-107 (a) Indications for allogenic bone marrow transplant include: (1) Severe aplastic anemia unresponsive to usual therapy; (2) Acute myelogenous leukemia in first remission; (3) Acute lymphocytic leukemia in second remission; and (4) Chronic leukemia after first year.

(b) Conditions and limitations affecting allogenic bone marrow transplant include: (1) Human leukocyte group A (HLA) histocompatible donor shall be available; (2) Patient has no other major systemic disease which would result in poor potential for recovery (such as a heart condition, liver disease, kidney damage, brain lesions, cancer in other organs or lung disease); (3) Patient shall have been properly evaluated by a qualified authority in Hawaii and bone marrow transplant is recommended as a possible curative procedure or if palliative, with reasonable likelihood for prolongation of life and return to an active life; (4) No active infection at the time of the procedure; (5) No general medical contraindication for the procedure and anesthesia; (6) Informed consent shall be obtained from the patient or the patient's representative; and (7) Age restricted to fifty or under except when identical twin is histocompatible and then

age limit may be fifty-five. [Eff 08/01/94 ] (Auth: HRS §346-14; 42 C.F.R. §431.10) (Imp: 42 C.F.R. §440.230; 42 U.S.C. §1396b(i))

§17-1737-94 Kidney transplant. (a) Indications are irreversible kidney failure that has progressed to a point that a useful, comfortable life can no longer be sustained by conventional medical treatment. The following conditions may deteriorate to the point when kidney transplant may be required: (1) Glomerulonephritis: (A) Proliferative; (B) Membranous; (C) Mesangio-capilliary; (2) Chronic pyelonephritis; (3) Hereditary: